ISOPROTERENOL IS A ␤-ADRENERGIC agonist that exerts its action through receptor-mediated stimulation of adenylate cyclase and subsequent elevation of intracellular cAMP (4, 5) . Increases in intracellular cAMP serve to activate cAMP-dependent protein kinase (PKA) (19) ; PKA is responsible for phosphorylating and thereby modulating the activity of a wide variety of molecules, including the CREB and CREM transcription factors (12) . This increase in PKA activity is thought to be primarily responsible for the subsequent downstream effects of cAMP.
Systemic exposure of mouse and rat parotid glands to isoproterenol results in massive protein secretion from these glands (6, 9) followed by glandular enlargement (26) . This glandular enlargement is marked by both hyperplasia (increased numbers of acinar cells) as well as hypertrophy (increased size of acinar cells) (8, 15) . DNA synthesis begins within 24 h (3), with maximal mitotic activity occurring 35 h after isoproterenol injection (10) . Along with the documented increase in DNA synthesis (24, 25) and mitotic activity within the parotid gland, there is an overall increase in glandular protein synthesis (16, 18) . Differential changes in RNA synthesis have also been noted, with some genes expressed in acinar cells being turned on or upregulated [proline-rich proteins (PRPs); 2, 29] and others being downregulated in response to exposure (␣-amylase; 22) .
In this study, we have used the DNA microarray technology to begin to characterize the early changes in gene expression within murine parotid glands in response to isoproterenol exposure. This system allows us to examine the in vivo effects of isoproterenol on the expression levels of nearly 6,500 genes and expressed sequence tags (ESTs) simultaneously. Through this type of analysis, we can begin to categorize the pathways and gene families involved in this response as well as potentially identify candidate genes that may be involved in the initiation of the observed acinar cell hypertrophy and hyperplasia.
METHODS
Isoproterenol treatment. Six-week-old male C57BL/6 NHSd mice weighing between 17.5 and 18.8 g were obtained from Harlan (Indianapolis, IN). All animals were fed ad libitum. After 7 days of acclimation, mice were given a single intraperitoneal injection of (Ϯ)-isoproterenol hydrochloride (0.025 g/kg prepared in 140 mM NaCl). Control mice received vehicle only. After 30 min, 2 h, 6 h, and 24 h of isoproterenol exposure, parotid glands were removed and snap-frozen in liquid nitrogen for subsequent RNA isolation. Five animals were used for each time point as well as for controls; parotid glands from the five animals composing each group were combined to generate the poly(A) ϩ RNA.
Preparation of poly(A)
ϩ RNA, cDNA, and biotin-labeled cRNA. The methods for preparation of the mRNA, cDNA, and cRNA were described in detailed protocols obtained from Affymetrix (Santa Clara, CA). Briefly, total RNA from parotid glands was isolated using Trizol reagent according to Article published online before print. See web site for date of publication (http://physiolgenomics.physiology.org).
manufacturer's instructions (Life Technologies). Poly(A) ϩ RNA was isolated using the Oligotex mRNA kit (Qiagen). mRNA was then precipitated, washed, and resuspended at a concentration of 1 mg/ml. cDNA was synthesized using the Superscript Choice System (Life Technologies) and the T7-(dT) 24 primer [dGGCCAGTGAATTGTAATACGACTCACTA-TAGGGAGGCGG-(dT)24] in place of the oligo dT primer provided with the kit. cRNA was synthesized using the T7 Megascript System (Ambion) supplemented with biotin-11-CTP and biotin-16-UTP (Enzo) and subsequently cleaned using RNeasy spin columns (Qiagen).
Target preparation. Biotinylated cRNA samples were fragmented at 95°C for 30 min in a solution of 40 mM Tris acetate, 500 mM KOAc, and 30 mM MgOAc. An aliquot of this was run on a 1% agarose gel to ensure the sample size was between 35 and 200 bases. A hybridization cocktail was prepared for each chip containing the following: 15 g cRNA, 100 mM MES, 1 M Na ϩ , 20 mM EDTA, 0.01% Tween 20, 0.1 mg/ml herring sperm DNA, and 0.5 mg/ml acetylated BSA. A control oligonucleotide (final concentration of 50 pM) and sequences representing bacterial control genes (BioB at 1.5 pM, BioC at 5 pM, BioD at 25 pM, and Cre at 100 pM) were also included in this mixture to aid in array alignment and to monitor levels of hybridization and detection. This cocktail was spun through an Amicon Micropure 0.22-m filter, then heated to 99°C for 5 min followed by 10 min at 45°C. The cocktail was again spun at 12,000 rpm for 5 min and added to the mouse GeneChip Mu6500 Set from Affymetrix. cRNA cocktails were incubated with GeneChip microarrays for 16 h at 45°C in a rotisserie oven.
Washing and staining and analysis of Affymetrix oligonucleotide arrays. Washing and staining were carried out on a GeneChip fluidics Station 400. The arrays were washed 10 times in buffer A (6ϫ SSPE, 0.01% Tween 20, 0.005% antifoam) followed by four washes in buffer B (100 mM MES, 0.1 M Na ϩ , 0.01% Tween 20) . The arrays were then stained for 10 min in SAPE (100 mM MES, 1 M Na ϩ , 0.05% Tween 20, 0.005% antifoam, 2 g/l BSA, and 10 g/ml streptavidin phycoerythrin). Following this stain, arrays are washed 10 times in wash buffer A. The arrays were removed from the fluidics station and scanned at 570 nm using a pixel value of 6 m on a Hewlett-Packard GeneArray laser-scanning device to generate non-antibody-stained files. The arrays were then stained a second time for antibody enhancement of the first stain. The arrays were stained for 10 min in antibody solution (100 mM MES, 1 M Na ϩ , 0.05% Tween 20, 0.005% antifoam, 2 g/l BSA, 1 g/l normal goat IgG, and 3 g/ml biotinylated goat anti-streptavidin antibody) and then stained again with SAPE for 10 min followed by 15 washes in buffer A at 30°C. Arrays were then scanned a second time to generate antibody-stained files. The second stain serves to enhance the signal of very-low-abundance genes. Values from the scanned arrays were analyzed using the GeneChip software. Normalization was performed based on the total intensity of all genes represented on the probe array and compared with a user-defined normalization factor generated from controls from previous experiments.
Genes showing sort scores of Ͼ1 or less than Ϫ1 and a greater than twofold change in expression level relative to the untreated control were kept for further analysis in Tables  1-4 and Figs. 1 and 2 . The sort score, as determined by the GeneChip software, provides a statistical evaluation of the differences in expression level of a gene between the experimental and baseline and is based on fold change and average difference change. The sort score is more reliable as the measured difference becomes larger.
Northern blot analysis. Mouse total RNA was electrophoresed on a 0.7% formaldehyde agarose gel and transferred to Hybond-N membranes (Amersham) according to Sambrook and Gething (23) . A 475-bp segment of the mouse Pim-1 gene (from IMAGE clone no. 553525; GenBank accession no. AA098418) was amplified by PCR using the primers PIM1-18-S, d(CGACGGCTTCTTGTTGGT), and PIM1-469-AS, d(TCAGGGAGAGACACCATT). This PCR product was labeled using the Random Primers DNA Labeling System (Life Technologies) according to manufacturer's instructions and used as a probe for Pim-1 transcripts. Antisense 18S ribosomal subunit oligonucleotide d(TATTGGAGCTGGAAT-TACCGCGGCTGCTGG) was end-labeled as described (27) and used to normalize sample loading by hybridizing with 5 M excess of probe. All hybridizations were performed in 5ϫ SSPE/50% formamide at 42°C with two final washes in 2ϫ SSC/0.1% SDS at 65°C for 20 min. Blots were exposed to Kodak XAR film at Ϫ70°C. Signals were quantitated using a Molecular Dynamics PhosphorImager.
RESULTS
To begin to define both the specific genes affected as well as the degree of the cellular response during the ␤-adrenergic stimulation elicited by isoproterenol within the parotid gland, we have taken advantage of the high-density oligonucleotide array technology. Parotid gland mRNA isolated from groups of mice treated with isoproterenol for 30 min, 2 h, 6 h, and 24 h as well as from controls was used to synthesize biotin-labeled cRNA. Labeled cRNA from each isoproterenol time point was hybridized to a mouse GeneChip Mu6500 Set and analyzed using GeneChip software. Genes displaying a sort score of Ͼ1 or less than Ϫ1 and a greater than twofold change in expression levels relative to vehicle-treated controls were categorized and annotated in Tables 1-4 (30 min, 2 h, 6 h, and 24 h isoproterenol treatment, respectively). General categories of cellular function of genes showing significant changes in expression levels included metabolism/biosynthesis, protein synthesis, gene expression, structural components, and stress response. Genes encoding Other other proteins, such as kinases, ATPases, signaling molecules, growth factors, ligands, receptors, and many of unknown function were also affected. After 30 min, 2 h, 6 h, and 24 h of isoproterenol exposure, a total of 22, 45, 48, and 42 genes showed significant changes in expression levels, respectively. The proline-rich proteins, which are known to increase in expression upon isoproterenol exposure (2, 29) , showed an increase in expression in this experimental system; similarly, a gene whose expression is known to decrease in response to isoproterenol (␣-amylase; Ref. 22) , was also found to decrease, validating the ability of this system to detect such changes in gene expression.
Graphs of genes displaying similar expression pattern changes over the isoproterenol time course are shown in Figs. 1 and 2 . Certain genes show a very rapid, but short-lived, increase in expression levels 30 min after isoproterenol treatment [ Fig. 1 , top left: N10 gene, protective protein (Mo54) gene, growth factorinducible immediate early gene, GADD45, major urinary protein IV], whereas others show more gradual increases to peaks at 2 h (Fig. 1, top To provide insight into the correctness of the kinetic pattern of the microarray experiment, we verified the expression level changes of the Pim-1 oncogene by Northern blot analysis of parotid gland total RNA. As is seen in Fig. 3 , expression of the Pim-1 gene is increased by 3.7-fold after 30 min to reach a peak of 14-fold induction after 2 h of isoproterenol treatment, once again validating the results obtained by the GeneChip methodology (see Fig. 1, top right) .
DISCUSSION
Exposure of mice and rats to the ␤-adrenergic agonist, isoproterenol, has been shown to cause marked hypertrophy and hyperplasia of parotid gland acinar cells through mechanisms that are largely unknown. We have used DNA microarrays to begin to define some of the changes in gene expression levels at various time points after systemic isoproterenol exposure. DNA microarrays allow one to examine the expression of thousands of genes in a given sample simultaneously. The arrays used in these experiments contain oligonucleotides representing nearly 6,500 mouse genes or ESTs. This analysis provided us with information about genes whose expression is rapidly increased in the presence of isoproterenol (Fig. 1, top) as well as those whose expression peaks after more extended times of Other treatment ( Fig. 1, bottom ). There were also many genes whose expression decreased upon exposure (Fig. 2) . Furthermore, the expression of many different categories of genes was affected by isoproterenol exposure; genes encoding cell cycle proteins, transcription factors, protein synthesis factors, signaling molecules, kinases, and structural proteins were all found to have altered expression levels, indicating the broad range of isoproterenol action/influence. All of these genes represent potential candidates for being involved in the physiological effects of isoproterenol. Although the time of induction in our experiment is difficult to directly compare to the known information in the literature because of differences in the time courses studied, the proline-rich proteins showed an increase in expression upon isoproterenol exposure, as previously shown (2, 29) ; similarly, ␣-amylase decreased, a gene whose expression is known to decrease in response to isoproterenol (22) . Genes whose expression peaks immediately after isoproterenol exposure may represent strong candidates for those acting as mediators of the subsequent downstream effects observed after extended treatment. One such gene identified in this study, Pim-1, was previously described as a proto-oncogene encoding a serine/threonine phosphokinase (17) . Overexpression of Pim-1 in mice results in a predisposition to lymphomagenesis (21) . Pim-1-deficient mice are apparently healthy and fertile, with the exception that they exhibit erythrocyte microcytosis; this decrease in erythrocyte mean cell volume is directly related to Pim-1 expression. These results implicate Pim-1 in some aspect of cell volume regulation within erythrocytes. It is not know what effect Pim-1 expression may have in the isoproterenol-induced hypertrophy/hyperplasia within parotid acinar cells. Future studies will attempt to address whether the same degree of hypertrophy/hyperplasia is observed in the Pim-1-deficient mice relative to wild-type controls.
Many genes from other systems have been implicated in the regulation of cell size and/or cell division. The Drosophila S6 kinase (DS6K) has been shown to reduce cell and body size when mutated (20) while the total number of cells remains the same. Components of the insulin signaling pathway have likewise been implicated in reduced cell size and number (7, 11) . Other studies have identified mutations within the genes involved in protein synthesis as responsible for re- duced cell growth and division (14) . In our current study, we have identified numerous genes involved in protein synthesis as well as a number of potential signaling molecules whose expression is altered in response to isoproterenol exposure. Future studies will investigate whether these genes contribute to the observed hypertrophy and hyperplasia of salivary gland acinar cells.
A recent DNA microarray study investigated isoproterenol-induced cardiac hypertrophy in mice (13) . A total of 32 genes out of 4,000 surveyed showed reproducible changes in expression levels upon isoproterenol treatment. As in the present study, many functional classes such as genes involved in metabolism, protein synthesis, signaling, and gene expression were affected.
This study represents an initial attempt to define and categorize the genes influenced by isoproterenol action within the parotid gland. Because the predominant cell type in this gland is acinar (70-80%), this model system provides a unique opportunity to investigate gene expression changes in a specific cell type in vivo. However, significant changes in gene expression within a minor cell type will also be detected in this study. Therefore, other confirmatory methods, such as in situ hybridization, will be needed to determine conclusively the cell type in which expression changes are occurring. It should also be noted that the samples used in this study were from pools of five individual mice; although pooling may aid in reducing the variability seen from individual to individual, more subtle changes in gene expression may go undetectable in these pools. Taking these caveats into consideration, we have identified a number of genes whose expression profile appears to be influenced by isoproterenol. Currently, there exist microarrays encompassing nearly 30,000 mouse genes and ESTs, with scanning devices capable of accurately detecting very minimal changes in gene expression. Future analyses should reveal an even larger set of genes influenced by systemic isoproterenol exposure. Such studies can also be extended into other tissues affected by isoproterenol to determine similarities in gene expression profiles. Ultimately, understanding the genes responsible for this glandular enlargement might also provide us with information regarding those involved in normal cell growth and division.
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